Recursion Pharmaceuticals, Inc. (RXRX)
NMS – Real Time Price. Currency in USD
3.29
-0.06 (-1.79%)
At close: Aug 12, 2026, 4:00 PM EDT
3.28
-0.01 (-0.30%)
After-hours: Aug 12, 2026, 5:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
3.29
-0.06 (-1.79%)
At close: Aug 12, 2026, 4:00 PM EDT
3.28
-0.01 (-0.30%)
After-hours: Aug 12, 2026, 5:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $551.1M significantly exceed its total debt $66.6M, ensuring strong financial flexibility
Total current assets $603.5M exceed Total current liabilities $119.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-436.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$106.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.03 | 6.05 | 10 | |
| Quick ratio | 5.03 | 5.63 | 10 | |
| Debt to Equity | 0.07 | 0.30 | 9.0 | |
| Debt to Assets | 0.06 | 1.04 | 9.0 | |
| Interest coverage | -436.79 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 40M | 45M | 59M | 75M | 55M |
| Gross Profit | -9M | -7M | -5M | -46M | -48M |
| Operating Income | -246M | -350M | -479M | -648M | -544M |
| Net Income | -239M | -328M | -464M | -645M | -519M |
| EBITDA | -226M | -318M | -443M | -564M | -466M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 191.06 | 39.96 | 10 |
| Next quarter | -39.86 | 1.45 | 2.0 |
| Current year | -25.6 | 38.29 | 5.5 |
| Next year | 34.06 | -2.45 | 5.5 |
| Weighted average score | 5.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 18.51 | -11.48 | -13.63 | -30.27 | 3.0 |
| Y/Y | -60.09 | 23.79 | 39.02 | -33.2 | 5.5 |
| 3y average | 23.6 | -39.11 | -2.77 | -58.12 | 3.3 |
| 5y average | 103.83 | -52.01 | -16.47 | -84.48 | 3.3 |
| Weighted average score | 3.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |